Home › NDC Lookup › J-codes › J9062
J9062

J9062 – Inj amivantamab 5mg hyaluron · NDC Crosswalk & Billing Units

HCPCS Level II J-code · Medicare Part B drug billing
J-code ● 4 NDCs crosswalked per 5 MG $40.743/unit ASP+6%

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

📋 J9062 summary

J9062 is a HCPCS Level II J-code used to bill amivantamab 5mg hyaluron, billed per 5 MG. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.

Brand names associated with J9062: Rybrevant Faspro

Code J9062 Billing unit 5 MG Payment limit $40.743/unit NDC-Crosswalk 4 Quarter Q3 2026 RxCUI Atlas Trace the drug concept →

⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.

🗂️ Key billing facts

HCPCS codeJ9062
DescriptorInj amivantamab 5mg hyaluron
Billing unit5 MG
Payment limit / unit$40.743
Est. ASP / unit$38.437 est.
Mapped NDCs4
Data periodQ3 2026
Last updated2026-08-20

🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026

📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$40.743
Est. ASP / unit
$38.437 est.
Est. after 2% sequester
$39.928
HCPCS dosage
5 MG
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.

🧮 Dosing & billing-units calculator HCPCS UNITS

One billing unit of J9062 = 5 mg. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.

🔁 NDCs that bill under J9062 WITH EST. MEDICARE PAY

4 NDCs map to J9062. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($40.743/unit) × that package's bill units.
NDC (11-digit)DrugLabelerPackageStrength Bill units Est. pay / pkg NADAC / unit StatusSource
57894-0510-01 Rybrevant Faspro AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT) 1600 mg/10mL; 20000 mg/10mL INJECTION Janssen 1 VIAL, SINGLE-DOSE in 1 CARTON (57894-510... 1600 mg/10mL; 20000 mg/10mL 320 $13,037.76 — ● Active CMS ASP
57894-0514-01 Rybrevant Faspro AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT) 2240 mg/14mL; 28000 mg/14mL INJECTION Janssen 1 VIAL, SINGLE-DOSE in 1 CARTON (57894-514... 2240 mg/14mL; 28000 mg/14mL 448 $18,252.86 — ● Active CMS ASP
57894-0515-01 Rybrevant Faspro AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT) 2400 mg/15mL; 30000 mg/15mL INJECTION Janssen 1 VIAL, SINGLE-DOSE in 1 CARTON (57894-515... 2400 mg/15mL; 30000 mg/15mL 480 $19,556.64 — ● Active CMS ASP
57894-0522-01 Rybrevant Faspro AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT) 3520 mg/22mL; 44000 mg/22mL INJECTION Janssen 1 VIAL, SINGLE-DOSE in 1 CARTON (57894-522... 3520 mg/22mL; 44000 mg/22mL 704 $28,683.07 — ● Active CMS ASP
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.

🗺️ Medicare utilization & spend CMS · PART B

No reportable public Medicare utilization was found for J9062. This is expected for newer codes, low-volume drugs, or codes whose use is billed under another code. CMS also hides any figure covering fewer than 11 patients (a privacy rule), so small-volume use may exist but isn't publishable. Utilization and spend appear here automatically once CMS publishes reportable data for this code.

🗃️ Data sources & freshness

Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Not available in current dataset
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q3 2026 · as of 2026-08-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk
4 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Not available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
No reportable utilization
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.

⚠️ Practical billing caveats

  • A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
  • Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
  • Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
  • Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
  • The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
  • Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.

❓ J9062 billing FAQ

What is HCPCS code J9062?
J9062 is a HCPCS Level II J-code used to bill Inj amivantamab 5mg hyaluron under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for J9062?
One unit of J9062 represents 5 MG. Report the number of units equal to the dose administered divided by 5 MG.
How many units of J9062 should I bill?
Divide the dose administered by the code's unit size (5 MG) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for J9062?
The Medicare Part B payment limit is $40.743 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $39.928 per unit. Payment limits are revised quarterly.
Which NDCs bill under J9062?
4 NDCs currently map to J9062 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J9062 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.